Join Dr. Sherly Mosessian, SOFIE's Chief Scientific Officer to discuss the Fibroblast Activation Protein (FAP)- A promising target for radiopharmaceuticals.

Visit SOFIE at the upcoming meeting from June 11 - 14, 2022 in Vancouver, Canada at Booth #319.

Presenter: Kimon Jackson, MSMP, MSA, CNMT Clinical Account Executive for SOFIE A Nuclear Medicine Technologist [...]

Visit SOFIE at the upcoming meeting from September 28 - October 1, 2022 in Miami, FL.

Visit SOFIE at the upcoming meeting from September 30 – October 2, 2022 in Bonita Springs, FL.

Presenter: Dr. Robert Bridwell, MD, MBA Medical Advisor at SOFIE Dr. Robert Bridwell, medical advisor [...]

In this webinar, Ms. Grabher will help you to understand the complex process companies go through when getting a radiopharmaceutical FDA approved.

Visit SOFIE at the upcoming Northern California Chapter SNMMI Annual Meeting on February 16, 2023 in Pleasanton, CA.

Visit SOFIE at The Future of Radiopharmaceuticals: Targeted Theranostic Therapeutics (digital conference)

Visit SOFIE at the upcoming Mid-Eastern Chapter of SNMMI Meeting from April 14-16, 2023 in Linthicum Heights, MD.

Dr. Sherly Mosessian will explain the significance of FAP as a target in oncology

Visit SOFIE at the upcoming 2nd Annual Targeted Radiopharmaceuticals Summit US from July 25-27, 2023 in Boston, MA